127 related articles for article (PubMed ID: 38632670)
1. Protective effects of COVID-19 vaccination in splenectomized patients with immune thrombocytopenia.
Liu X; Gan X; Xu J; Wang Y; Huang J; He X; Li Y; Gong Y; Peng B; Niu T
Br J Haematol; 2024 Jun; 204(6):2217-2221. PubMed ID: 38632670
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
Lee EJ; Beltrami-Moreira M; Al-Samkari H; Cuker A; DiRaimo J; Gernsheimer T; Kruse A; Kessler C; Kruse C; Leavitt AD; Lee AI; Liebman HA; Newland AC; Ray AE; Tarantino MD; Thachil J; Kuter DJ; Cines DB; Bussel JB
Blood; 2022 Mar; 139(10):1564-1574. PubMed ID: 34587251
[TBL] [Abstract][Full Text] [Related]
3. Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.
Ruzicka M; Wurm S; Lindner L; Dreyling M; von Bergwelt-Baildon M; Boeck S; Giessen-Jung C; Milani V; Stemmler JH; Subklewe M; Weigert O; Spiekermann K
Infection; 2023 Feb; 51(1):231-238. PubMed ID: 36195695
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccination in patients with immune thrombocytopenia.
Visser C; Swinkels M; van Werkhoven ED; Croles FN; Noordzij-Nooteboom HS; Eefting M; Last-Koopmans SM; Idink C; Westerweel PE; Santbergen B; Jobse PA; Baboe F; ; Te Boekhorst PAW; Leebeek FWG; Levin MD; Kruip MJHA; Jansen AJG
Blood Adv; 2022 Mar; 6(6):1637-1644. PubMed ID: 34941989
[TBL] [Abstract][Full Text] [Related]
5. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
[TBL] [Abstract][Full Text] [Related]
6. Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual.
Ogai A; Yoshida R; Yuasa C; Chin K; Fujimaki K; Nakajima H
Int J Hematol; 2022 Feb; 115(2):293-295. PubMed ID: 34716890
[No Abstract] [Full Text] [Related]
7. Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France.
Moulis G; Lapeyre-Mestre M; Mahévas M; Montastruc JL; Sailler L
Am J Hematol; 2015 Apr; 90(4):301-5. PubMed ID: 25557586
[TBL] [Abstract][Full Text] [Related]
8. Infections in non-splenectomized persistent or chronic primary immune thrombocytopenia adults: risk factors and vaccination effect.
Moulis G; Lapeyre-Mestre M; Palmaro A; Sailler L
J Thromb Haemost; 2017 Apr; 15(4):785-791. PubMed ID: 28078756
[TBL] [Abstract][Full Text] [Related]
9. Severe case of refractory immune thrombocytopenic purpura requiring splenectomy after the COVID-19 vaccine.
Koilpillai S; Dominguez B; Khan A; Carlan S
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35725277
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics in immune thrombocytopenia patients after COVID-19 vaccination.
Feng Y; Quan Y; Cassady K; Zou Z; Gao Y; Zhang X
Hum Vaccin Immunother; 2022 Nov; 18(6):2119043. PubMed ID: 36069667
[TBL] [Abstract][Full Text] [Related]
11. Fulminant sepsis in adults splenectomized for idiopathic thrombocytopenic purpura.
Rodeghiero F; Frezzato M; Schiavotto C; Castaman G; Dini E
Haematologica; 1992; 77(3):253-6. PubMed ID: 1427432
[TBL] [Abstract][Full Text] [Related]
12. Long-term complications of splenectomy in adult immune thrombocytopenia.
Thai LH; Mahévas M; Roudot-Thoraval F; Limal N; Languille L; Dumas G; Khellaf M; Bierling P; Michel M; Godeau B
Medicine (Baltimore); 2016 Nov; 95(48):e5098. PubMed ID: 27902585
[TBL] [Abstract][Full Text] [Related]
13. Effects of COVID-19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia.
Kaicker S; Martinko K; Bussel JB
Pediatr Blood Cancer; 2023 Jan; 70(1):e30051. PubMed ID: 36317671
[TBL] [Abstract][Full Text] [Related]
14. Humoral response to mRNA-based COVID-19 vaccine in patients with immune thrombocytopenia.
Mori A; Onozawa M; Kobayashi M; Tsukamoto S; Senjo H; Ishio T; Yokoyama E; Izumiyama K; Saito M; Muraki H; Morioka M; Teshima T; Kondo T
Br J Haematol; 2023 Mar; 200(6):717-721. PubMed ID: 36442510
[TBL] [Abstract][Full Text] [Related]
15. Vaccine-associated thrombocytopenia.
Gan G; Liu H; Liang Z; Zhang G; Liu X; Ma L
Thromb Res; 2022 Dec; 220():12-20. PubMed ID: 36265409
[TBL] [Abstract][Full Text] [Related]
16. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).
Paulsen FO; Schaefers C; Langer F; Frenzel C; Wenzel U; Hengel FE; Bokemeyer C; Seidel C
Blood; 2021 Sep; 138(11):996-999. PubMed ID: 34297792
[No Abstract] [Full Text] [Related]
17. Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.
Bidari A; Asgarian S; Pour Mohammad A; Naderi D; Anaraki SR; Gholizadeh Mesgarha M; Naderkhani M
Eur J Haematol; 2023 Apr; 110(4):335-353. PubMed ID: 36562217
[TBL] [Abstract][Full Text] [Related]
18. Real-world, single-center experience of SARS-CoV-2 vaccination in immune thrombocytopenia.
Woolley P; Tailor A; Shah R; Westwood JP; Scully M
J Thromb Haemost; 2022 Jun; 20(6):1476-1484. PubMed ID: 35313390
[TBL] [Abstract][Full Text] [Related]
19. Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.
Fueyo-Rodriguez O; Valente-Acosta B; Jimenez-Soto R; Neme-Yunes Y; Inclán-Alarcón SI; Trejo-Gonzalez R; García-Salcido MÁ
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34059544
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of SARS-CoV-2 vaccination in patients with immune thrombocytopenia: A two-centre review.
Stefani S; Buti N; Hart ACJ; Paul D; Rizvi N; Ragoonanan V; Vladescu C; Szydlo R; Ademokun C; Jansen AJG; Cooper N
Br J Haematol; 2024 Jan; 204(1):324-328. PubMed ID: 38013240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
